CELGENE CORPORATION

Form 483 issued December 6, 2024 · SUMMIT, New Jersey

Inspection
Dec 2 – Dec 6, 2024
Investigator
Tyanna N. Hadley
Observations
4
Pages
4
FEI number
3004991673

In short: On December 6, 2024, FDA issued a Form 483 with 4 observations to CELGENE CORPORATION in SUMMIT, New Jersey (FEI 3004991673) after an inspection that ran Dec 2 – Dec 6, 2024. The investigator was Tyanna N. Hadley.

What FDA observed

Preview: the opening words of each observation
  1. 01
    FDCA 505-1(f)(4)

    An application holder did not comply with the audit plan and schedule described in the REMS…

  2. 02
    FDCA 505-1(f)(3)(E)

    EMPLOVEE,S) SGAATURE DATEISSUED An application holder did not instruct healthcare providers or health care facilities to…

  3. 03
    FDCA 505-1(f)(3)(A)

    An application holder did not make training available to prescribing healthcare providers (HCPs), as required by…

  4. 04
    FDCA 505-1(f)(3)(B)

    An application holder did not ensure mechanisms are in place that allow pharmacies the ability to…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at CELGENE CORPORATION?

FDA listed 4 observations on this Form 483. The opening words of each observation are shown on this page.

Who inspected CELGENE CORPORATION?

Tyanna N. Hadley is named on this Form 483, for the inspection of Dec 2 – Dec 6, 2024. Each investigator has a profile showing what they cite most.

When was CELGENE CORPORATION inspected by FDA?

The inspection ran Dec 2 – Dec 6, 2024, and the Form 483 is dated December 6, 2024.

How do I get the full Form 483 for CELGENE CORPORATION?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free